AUTOMA+ 2026 : Pharmaceutical Automation and Digitalisation Congress 2026

Start:

Mon, 16 Nov 2026, 09:00

End:

Mon, 17 Nov 2025, 13:00

Website:

https://iii.hm/automa2026

Venue:

Exhibit

Symposia

Workshops

Organiser

Sponsor

The Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) 2026 is a closed-door event that focuses on the end-to-end digital transformation - from R&D and laboratory automation to manufacturing, packaging, supply chain, compliance and commercial operations. Hosted in Zurich on 16-17 November 2026, the Congress addresses the real constraints shaping digital transformation in pharma - from data integrity and validation to scalability and return on investment.

More than 50 speakers contribute to the agenda, covering:

● Pharma 4.0 with AI and advanced analytics;

● R&D and laboratory automation;

● next-generation digital solutions for GxP compliance;

● quality management and modification of pharma logistics;

● patient-centric digital commercial and marketing strategies;

● real-world data applications and others.

AUTOMA+ 2026 features perspectives from GSK, Takeda, Novartis, Roche, Johnson & Johnson, SCARLETRED Holding GmbH, WHO and others, reflecting a cross-section of pharmaceutical manufacturing, research, public health and technology expertise. With its focus on applied use cases, AUTOMA+ 2026 demonstrates the practical implementation of automation and digitalisation across regulated pharmaceutical environments today.

Find out where pharma automation stands today: https://sh.bgs.group/3ve

Register Now

Programme

The Business Programme of AUTOMA+ is created to cover major pharma industry processes, alongside the integration of digital solutions that enhance efficiency and effectiveness. Topics include newest case studies from our long term partners including pharma majors, contract manufacturing & research companies, local pharma companies, APIs, associations and service providers.

Every topic is carefully selected to ensure the Programme includes only the most relevant, up-to-date, and thought-provoking cases. This approach guarantees that the agenda reflects the newest trends and pressing challenges in pharmaceutical automation and digitalisation, providing the audience with insights that inspire discussion and spark meaningful exchange.